The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.
The judge presiding over all federal Bard PowerPort lawsuits will meet with lawyers today to review the status of pretrial proceedings and the selection of the next round of bellwether cases.
Court has ordered parties to meet separately with a U.S. Magistrate Judge over the next two months, to discuss the best timing and structure for settlement negotiations to resolve Change Healthcare data breach lawsuits.
